16 results
DEFR14A
ARCT
Arcturus Therapeutics Holdings Inc
12 May 22
Revised proxy
5:00pm
and uncertainty. As a result, we believe our ability to hire, appoint, and retain key personnel would be negatively impacted by a failure to approve
8-K
EX-14.1
fb2 jdl65qdut
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
10-K
emgamf3fou4
16 Mar 20
Annual report
11:09am
10-K
EX-10.24
9yne633nc
16 Mar 20
Annual report
11:09am
DEF 14A
0u559yq etr
1 Oct 19
Definitive proxy
6:07am
424B3
o85k90x4g
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
5x59 e48oz4p
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
S-4
app39 s9xz35kv0c6gjy
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
- Prev
- 1
- Next